What are the Therapeutic Implications of Protein Expression in Cancer?
Targeting protein expression in cancer has led to the development of several effective therapies. For instance: - Monoclonal Antibodies: These are designed to bind specific proteins, such as HER2 in breast cancer, to inhibit their function. - Small Molecule Inhibitors: These target specific proteins involved in cancer cell signaling pathways, such as EGFR inhibitors. - Proteasome Inhibitors: These disrupt protein degradation pathways in cancer cells, leading to the accumulation of toxic proteins.
